University of Strathclyde spin-out is developing liquid biopsies for early cancer detection
Category: Uncategorized
Sanofi is also planning an EU regulatory submission for Dupixent in the same indication
Updated Date: Thu, 25 Feb 2021 00:00:00 EST
A year into Sanofi’s revamp, CEO Paul Hudson collects €11.34M in 2020 pay—including that signing bonus esagonowsky Thu, […]
A High Court judge has quashed a tribunal’s decision to strike a consultant orthopaedic surgeon off the UK […]
CureVac, Novartis team up in latest pandemic vaccine manufacturing collaboration esagonowsky Thu, 03/04/2021 – 09:24
Biogen cements gene therapy ambitions with $200M factory in Research Triangle fkansteiner Thu, 03/04/2021 – 10:08
Pfizer’s Lorbrena breaks into front-line ALK lung cancer, jostling with Novartis, Roche and Takeda aliu Thu, 03/04/2021 – […]
Despite strong data from a would-be rival, Sanofi and Regeneron’s Dupixent can grow in asthma: analyst esagonowsky Thu, […]